Meanwhile, KEGG outcomes revealed that CBX8 was majorly centered in transcriptional misregulation in cancer, signaling pathways regulating pluripotency of stem cells, systemic lupus, erythematosus, and other processes (Figure 9(c)), consistent with van Wijnen et al.'s report [2]. Here, CBX8 is linked to cancer.